Pancreatitis
📧 Sign up to get email alerts when something new happens for Pancreatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-07-11Clinical Trial Update: Italian Registry Chronic Pancreatitis
Clinical trial registry entry for an Italian study on Chronic Pancreatitis, sponsored by Associazione Italiana per lo Studio del Pancreas; c…
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: Tocilizumab for Painful Chronic Pancreatitis [Phase 2]
Phase 2 trial of tocilizumab for painful chronic pancreatitis is currently recruiting. The study is sponsored by Soren Schou Olesen.
-
CLINICAL_TRIALS trial_result · 2024-06-24Clinical Trial Update: A Predictive Model for Recurrent Acute Pancreatitis
The trial has completed and reports the development and validation of a predictive model for recurrent acute pancreatitis.
-
CLINICAL_TRIALS research · 2024-06-20Clinical Trial Update: Prophylactic Tributyrin Supplementation in Acute Pancreatitis [Phase 2]
A Phase 2 clinical trial is evaluating prophylactic tributyrin supplementation for acute pancreatitis and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-06-11Clinical Trial Update: PRIMARY NEEDLE KNIFE FISTULOTOMY
A clinical trial evaluating primary needle-knife fistulotomy for pancreatitis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-06-06Clinical Trial Update: Clinical Outcome After Total Pancreatectomy With Islet Autotransplantation
This document provides a clinical outcome update from a trial evaluating total pancreatectomy with islet autotransplantation.
-
CLINICAL_TRIALS research · 2024-06-06Clinical Trial Update: Arginine-stimulated Indication of Early Outcome After Islet Transplantation
Leiden University Medical Center is conducting a clinical trial (NCT05540197) to assess early outcomes after islet transplantation using arg…
-
CLINICAL_TRIALS trial_result · 2024-05-22Clinical Trial Update: Efficacy and Safety of Evinacumab in Adult Patients With Severe Hypertriglyceridemia for the Prevention of Recurrent Acute Pancreatitis [Phase 2]
Phase 2 study of evinacumab in adults with severe hypertriglyceridemia for prevention of recurrent acute pancreatitis has been terminated; r…
-
CLINICAL_TRIALS research · 2024-05-22Clinical Trial Update: Quality of Life Assessment of Chronic Pancreatitis Endoscopic Interventions
The clinical trial assesses quality of life after endoscopic interventions for chronic pancreatitis, with enrollment ongoing by invitation.
-
CLINICAL_TRIALS research · 2024-05-22Clinical Trial Update: ESWL vs. Pancreatoscopy-guided Lithotripsy for Painful Chronic Calcific Pancreatitis [NA]
This clinical trial compares ESWL versus pancreatoscopy-guided lithotripsy for painful chronic calcific pancreatitis, and is currently enrol…
-
CLINICAL_TRIALS other · 2024-05-13Clinical Trial Update: Gastrointestinal Microflora and Serum Metabolomics in Patients With Pancreatic Cancer and Chronic Pancreatitis
A clinical trial is currently recruiting to study gastrointestinal microflora and serum metabolomics in patients with pancreatic cancer and …
-
CLINICAL_TRIALS research · 2024-05-09Clinical Trial Update: Natural Course and Therapeutic Effect of Recurrent Acute Pancreatitis
A clinical trial update shows that a cohort study evaluating the natural course and potential therapies for recurrent acute pancreatitis is …
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: Pancreatitis - Microbiome As Predictor of Severity [NA]
A completed clinical trial study investigates whether the microbiome can predict severity in acute pancreatitis.
-
CLINICAL_TRIALS trial_result · 2024-03-21Clinical Trial Update: Effects of a Peripherally Acting µ-opioid Receptor Antagonist on Recurrent Acute Pancreatitis [Phase 2, Phase 3]
A clinical trial update for a peripherally acting µ-opioid receptor antagonist assessing effects in recurrent acute pancreatitis across Phas…
-
FDA approval · 2024-02-28FDA Approved: PERTZYE — Supplemental Application (Digestive Care, Inc.)
FDA approved a supplemental application for PERTZYE (pancrelipase) submitted by Digestive Care, Inc.
-
FDA approval · 2024-02-28FDA Approved: PANCREAZE — Supplemental Application (VIVUS LLC)
FDA approved a supplemental application for PANCREAZE, a pancreatic enzyme replacement product, submitted by VIVUS LLC.
-
CLINICAL_TRIALS trial_result · 2024-02-01Clinical Trial Update: Role of a CCK Receptor Antagonist Proglumide in Management of Chronic Pancreatitis [Phase 1, Phase 2]
Clinical trial update on proglumide, a CCK receptor antagonist, for safety and pain management in chronic pancreatitis (Phase 1/Phase 2).
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: Spinal Cord Stimulation for the Treatment of Pain in Chronic Pancreatitis [Phase 2]
A Phase 2 clinical trial evaluating spinal cord stimulation for pain in chronic pancreatitis has completed.
-
FDA approval · 2023-11-20FDA Approved: VIOKACE — Supplemental Application (Aimmune Therapeutics, Inc.)
FDA approved a supplemental application for VIOKACE (pancrelipase) to update and expand its labeling. The action supports additional indicat…
-
FDA approval · 2023-10-27FDA Approved: ZENPEP — Supplemental Application (Aimmune Therapeutics, Inc.)
The FDA approved a supplemental application for ZENPEP (pancrelipase) submitted by Aimmune Therapeutics, Inc., updating its labeling for exo…
-
CLINICAL_TRIALS trial_result · 2023-10-02Clinical Trial Update: Intravenous Lidocaine for Pain Associated With Pancreatic Cancer and Chronic Pancreatitis [Phase 2]
Phase 2 clinical trial evaluating intravenous lidocaine for pain in pancreatic cancer and chronic pancreatitis has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-08Clinical Trial Update: Safety and Efficacy of SCM-AGH in Patients With Moderate to Severe Acute Pancreatitis [Phase 1, Phase 2]
Clinical trial update for SCM-AGH in acute pancreatitis reports safety and efficacy data across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2023-05-09Clinical Trial Update: Alpha-1 Antitrypsin (AAT) Enhances Islet Autograft Survival in Patients With Chronic Pancreatitis [Phase 1, Phase 2]
A clinical trial evaluating alpha-1 antitrypsin (AAT) to enhance islet autograft survival in chronic pancreatitis has completed Phase 1/2 wi…
-
CLINICAL_TRIALS research · 2023-04-21Clinical Trial Update: Effects of Peripherally Acting µ-opioid Receptor Antagonists on Acute Pancreatitis [Phase 2, Phase 3]
Clinical trial update on peripherally acting mu-opioid receptor antagonists for acute pancreatitis across Phase 2 and Phase 3.
-
FDA approval · 2023-03-24FDA Approved: FENOFIBRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for fenofibrate submitted by Mylan Pharmaceuticals Inc., for a generic fenofibrate product.